Mereo BioPharma Group PLC (MREO)
2.98
-0.04
(-1.16%)
USD |
NASDAQ |
May 08, 11:11
Mereo BioPharma Group Price: 2.98 for May 8, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 07, 2024 | 3.09 | 3.13 | 2.97 | 3.015 | 684469.0 |
| May 06, 2024 | 3.30 | 3.31 | 3.01 | 3.10 | 835729.0 |
| May 03, 2024 | 3.16 | 3.35 | 3.14 | 3.26 | 855585.0 |
| May 02, 2024 | 3.18 | 3.24 | 3.11 | 3.11 | 431767.0 |
| May 01, 2024 | 3.06 | 3.22 | 3.01 | 3.15 | 1.962M |
| Apr 30, 2024 | 2.75 | 3.09 | 2.71 | 3.05 | 1.579M |
| Apr 29, 2024 | 2.75 | 2.815 | 2.670 | 2.76 | 530508.0 |
| Apr 26, 2024 | 2.81 | 2.81 | 2.73 | 2.74 | 562550.0 |
| Apr 25, 2024 | 2.75 | 2.82 | 2.64 | 2.81 | 1.031M |
| Apr 24, 2024 | 2.76 | 2.885 | 2.76 | 2.78 | 748362.0 |
| Apr 23, 2024 | 2.81 | 2.851 | 2.75 | 2.78 | 790452.0 |
| Apr 22, 2024 | 2.73 | 2.81 | 2.620 | 2.79 | 1.065M |
| Apr 19, 2024 | 2.62 | 2.668 | 2.53 | 2.64 | 912723.0 |
| Apr 18, 2024 | 2.56 | 2.675 | 2.525 | 2.65 | 814717.0 |
| Apr 17, 2024 | 2.70 | 2.71 | 2.58 | 2.58 | 601205.0 |
| Apr 16, 2024 | 2.68 | 2.70 | 2.61 | 2.69 | 591800.0 |
| Apr 15, 2024 | 2.68 | 2.720 | 2.605 | 2.67 | 1.251M |
| Apr 12, 2024 | 2.80 | 2.820 | 2.64 | 2.72 | 1.311M |
| Apr 11, 2024 | 2.96 | 2.997 | 2.72 | 2.74 | 1.651M |
| Apr 10, 2024 | 3.03 | 3.07 | 2.93 | 2.94 | 776215.0 |
| Apr 09, 2024 | 3.18 | 3.18 | 2.984 | 3.13 | 851304.0 |
| Apr 08, 2024 | 3.27 | 3.27 | 3.14 | 3.17 | 628091.0 |
| Apr 05, 2024 | 3.23 | 3.36 | 3.180 | 3.29 | 710458.0 |
| Apr 04, 2024 | 3.46 | 3.468 | 3.19 | 3.26 | 952020.0 |
| Apr 03, 2024 | 3.38 | 3.48 | 3.32 | 3.41 | 604605.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.33
Minimum
May 11 2022
5.42
Maximum
May 10 2019
2.126
Average
2.10
Median
Nov 22 2019
Price Benchmarks
| Biodexa Pharmaceuticals Plc | 1.04 |
| NuCana PLC | 3.97 |
| TC BioPharm (Holdings) PLC | 1.25 |
| Adaptimmune Therapeutics PLC | 1.055 |
| Autolus Therapeutics PLC | 4.105 |
Price Related Metrics
| PS Ratio | 39.30 |
| Price to Book Value | 8.271 |
| Earnings Yield | -6.71% |
| Market Cap | 418.01M |